Zenith Drugs Limited IPO is an NSE SME IPO. They are going to raise ₹40.68 Crores via IPO. The issue is priced at ₹75 to ₹79 per equity share. The IPO is to be listed on NSE.
Zenith Drugs Limited IPO opens for subscription on February 19, 2024, and closes on February 22, 2024. The allotment for the Zenith Drugs Limited IPO is expected to be finalized on February 23, 2024. Zenith Drugs Limited IPO will list on NSE SME with tentative listing date fixed as Friday, February 27, 2024.
| Zenith Drugs Limited | NSE SME |
| Minimum Investment ₹126,400 /1 Lot (1600 shares) | Price Range ₹75-₹79 | |
| Max Quantity 1 Lots/1600 Shares | Max Investment ₹126,400 | Retail Discount ₹0 |
| Investor category and subcategory Individual- HNI & Retail | Issue Size 40.68 Cr | Employee Discount ₹0 |
| Total Issue Size 5,148,800 Shares (aggregating up to ₹40.68 Cr) | Share Holding Pree Issue 12,000,000 | Issue Type Book Built Issue IPO |
| Fresh Issue Share 5,148,800 Shares (aggregating up to ₹40.68 Cr) | Share Holding Post Issue 17,148,800 | Listing At NSE SME |
| Market Maker Portion 852,800 shares (Gretex share Broking) | Face value ₹10 pr share. |
IPO Dates
| Offer Starts | 19 Feb 2024 |
| Offer Ends | 22 Feb 2024 |
| Allotment | 23 Feb 2024 |
| Refunds | 26 Feb 2024 |
| Credit of shares to Demat account | 26 Feb 2024 |
| IPO Listing | 27 Feb 2024 |
About Zenith Drugs Limited
Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specialising in manufacturing and trading high-quality, affordable medicines, including generic drugs.
They are proud to be WHO-GMP compliant, adhering to the stringent guidelines set by the World Health Organization. Their commitment to quality is further demonstrated by their ISO 9001:2015 certification, obtained from a respected EuroUK certification body. Zenith offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules.
The product portfolio of the company includes
ORS Powder;
Liquid Orals;
Ointments;
Liquid Externals; and
Capsules
The Food & Drugs Administration has approved over 600 products, of which 325 are currently in production.
The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.
The company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan, Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.
Zenith Drugs Limited specializes in third-party manufacturing, also known as white label manufacturing, for esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.
| Incorporated in | Managing Director |
| 2000 | Mr. Sandeep Bharadwaj |
Share Holding
| Share Holding Pre-Issue | 100% |
| Share Holding Post-Issue | 69.98% |
Zenith Drugs Limited IPO Prospectus
| Zenith Drugs Limited IPO Prospectus | |
| DRHP Draft Prospectus | Click Here |
| RHP Draft Prospectus | Click Here |
Financials
| Year | SEP 2023 | MAR 2023 | 2022 |
| Revenue | ₹6,948.43 | ₹11,569.65 | ₹9,266.63 |
| Assets | ₹11,249.04 | ₹9,793.83 | ₹6,858.47 |
| Profit | ₹539.38 | ₹515.29 | ₹312.86 |
Fundamentals
| Values | Values | ||
| Market cap | 135.48 Cr | ROE | 35.13% |
| P/E (X) | 18.4 | ROCE | 37.29% |
| POST P/E (X) | 12.56 | EPS | 4.29 |
| Debt to Equity | 1.51 | RONW | 29.88% |
Objects of the Issue
- Purchase of Machinery & Equipments for Setting up New Unit.
- Existing Manufacturing Block Upgradation
- Working Capital Requirements
- General Corporate Purposes.
Brokerage Firm IPO Review
- To be updated soon
| Zenith Drugs Limited Contact Details | |
| Address | Zenith Drugs Limited K. No. 72 / 5, Village Muradpura NA Depalpur, Indore-453001 |
| Phone: | +91 8435501867 |
| info@zenithdrugs.com | |
| Website | https://zenithdrugs.com/ |
| Zenith Drugs Limited IPO Registrar | |
| . | Bigshare Services Pvt Ltd |
| Phone | +91-22-6263 8200 |
| ipo@bigshareonline.com | |
| Website | http://www.bigshareonline.com |
| Zenith Drugs Limited IPO Allotment Status Check |
| Zenith Drugs Limited IPO Allotment Status Check Click Here |
| Zenith Drugs Limited Lead Managers | |
| Gretex Corporate Services Pvt Ltd Office No. 13, 1st Floor, Raja Bahadur Mansion, New Bansilal Building, 9 -15, HomiModi Street , Fort, Near BSE Ltd, Mumbai -400023 | |
| Phone | +91 22 6708 6181 |
| ipo@gretexgroup.com | |
| Website | http://www.gretexcorporate.com |
Zenith Drugs Limited IPO FAQs
What is Zenith Drugs Limited IPO?
- Zenith Drugs Limited IPO is an NSE SME IPO. They are going to raise ₹40.68 Crores via IPO. The issue is priced at ₹75 to ₹79 per equity share. The IPO is to be listed on NSE.
When Zenith Drugs Limited IPO will open?
- The IPO is to open on February 19, 2023, for NII, and Retail Investors.
What is Zenith Drugs Limited IPO Investors Portion?
- The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
What is Zenith Drugs Limited IPO Size?
- Zenith Drugs Limited IPO size is ₹40.68 crores.
What is Zenith Drugs Limited IPO Price Band?
- Zenith Drugs Limited IPO Price Band is ₹75 to ₹79 per equity share.
What is Zenith Drugs Limited IPO Minimum and Maximum Lot Size?
- The IPO bid is Minimum 1 Lot (1600 Shares) with ₹126.400. and Maximum Lot Size 1 Lots (1600 Shares) with ₹126,400
What is Zenith Drugs Limited IPO Allotment Date?
- Zenith Drugs Limited IPO allotment date is February 23, 2024.
What is Zenith Drugs Limited IPO Listing Date?
- Zenith Drugs Limited IPO listing date is February 27, 2024. The IPO to list on NSE.